Compounds > procyanidin b2
Page last updated: 2024-09-03

procyanidin b2 and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

procyanidin b2 has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chai, YH; He, XX; Jing, YX; Li, HX; Ma, XL; Sun, XH; Xi, YM; Xue, SL1

Other Studies

1 other study(ies) available for procyanidin b2 and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Mechanism of Procyanidin B2 in the Treatment of Chronic Myeloid Leukemia Based on Integrating Network Pharmacology and Molecular Docking.
    Anti-cancer agents in medicinal chemistry, 2023, Volume: 23, Issue:16

    Topics: Drugs, Chinese Herbal; ErbB Receptors; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Docking Simulation; Network Pharmacology

2023